东诚药业：原副总经理吴晓明先生和证券事务代表李季先生由于工作调整原因申请辞去相关职务

Core Viewpoint - Dongcheng Pharmaceutical (002675) announced on October 21 that its former Vice President Wu Xiaoming and Securities Affairs Representative Li Ji have resigned from their positions due to work adjustments [1] Group 1 - The company confirmed the resignation of two key personnel, indicating potential changes in management structure [1] - The reasons for the resignations were attributed to work adjustments, suggesting possible internal restructuring [1]